British GlaxoSmithKline announced the purchase of American Tesaro for 5 billion 100 million dollars


British pharmaceutical company GlaxoSmithKline has entered into an agreement with American Tesaro, which suggests that the company from the UK will buy an American pharmaceutical company for 5 billion 100 million dollars. The closing of the deal should take place in the first quarter of next year. Thanks to the acquisition of Tesaro, GlaxoSmithKline’s portfolio will be replenished with a variety of different products developed and manufactured by Tesaro and aimed at treating cancer.

The information and recommendations contained in this analytical document are published strictly for information purposes and are not considered as an offer to buy or sell the trading tools mentioned above and are not intended to motivate to perform certain transactions
Something went wrong